2m 2m 2m 2m 2m 2m 2m
ELICIO THERAPTCS (ELTX)
NASDAQ
$2.85-$0.010 (-0.35%)
Price as of Aug 03, 2026 7:34 PM EDT- $73.5MMarket Cap
- -71.20%1-Year Change
- BiotechnologyIndustry
ELICIO THERAPTCS (ELTX)
$2.85-$0.010 (-0.35%)
ELTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.86 | ||
Change | +$0.06 (+2.14%) | ||
Open | $2.78 | ||
High | $2.90 | ||
Low | $2.75 | ||
Previous Close | $2.80 | ||
Volume | 293,731 | ||
30-Day Average Volume | 713,319 | ||
1-Week Change | -4.67% | ||
1-Month Change | -11.18% | ||
1-Year Change | -71.20% | ||
3-Year Change | -71.26% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 26.3M | ||
Total Assets | $22.7M | ||
Market Cap | $73.5M | ||
Enterprise Value | $68.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$11.8M | ||
Free Cash Flow | -$11.6M | ||
EBIT | -$11.8M | ||
EBITDA | -$11.8M | ||
Net Working Capital | $9.0M | ||
EPS | -$0.65 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -51 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue